JP2025519127A5 - - Google Patents
Info
- Publication number
- JP2025519127A5 JP2025519127A5 JP2024569387A JP2024569387A JP2025519127A5 JP 2025519127 A5 JP2025519127 A5 JP 2025519127A5 JP 2024569387 A JP2024569387 A JP 2024569387A JP 2024569387 A JP2024569387 A JP 2024569387A JP 2025519127 A5 JP2025519127 A5 JP 2025519127A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- identity
- pain
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22305773.8 | 2022-05-25 | ||
| EP22305773 | 2022-05-25 | ||
| PCT/EP2023/064091 WO2023227731A1 (en) | 2022-05-25 | 2023-05-25 | Peptides and methods for use in treating pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025519127A JP2025519127A (ja) | 2025-06-24 |
| JP2025519127A5 true JP2025519127A5 (cg-RX-API-DMAC7.html) | 2026-05-18 |
Family
ID=81975215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024569387A Pending JP2025519127A (ja) | 2022-05-25 | 2023-05-25 | 疼痛の処置で使用されるペプチド及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250213654A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4531886A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025519127A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250017221A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119730868A (cg-RX-API-DMAC7.html) |
| AR (1) | AR129441A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023275937A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3253053A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL317048A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024014419A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202409064A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023227731A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026119985A1 (en) * | 2024-12-03 | 2026-06-11 | Tafalgie Therapeutics | Peptides for use in treating wounds and inflammatory diseases |
| WO2026119983A1 (en) | 2024-12-03 | 2026-06-11 | Tafalgie Therapeutics | Peptides for use in treating pain, wounds and inflammatory diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11514853A (ja) | 1995-09-08 | 1999-12-21 | ジエンザイム コーポレイション | 遺伝子治療のための改良されたaavベクター |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| WO2006013462A2 (en) * | 2004-07-30 | 2006-02-09 | Nsgene A/S | Growth factors nsg28, nsg30, and nsg32 |
| CN103382220A (zh) * | 2012-05-03 | 2013-11-06 | 北京大学 | 具有抗感染、抗肿瘤活性的细胞因子fam19a4及其应用 |
| EP2801369A1 (en) | 2013-05-06 | 2014-11-12 | Centre National De La Recherche Scientifique | TAFA4 compounds and uses thereof for treating pain |
| CN108699604A (zh) | 2016-03-08 | 2018-10-23 | 艾克斯-马赛大学 | 用于预测急性疼痛转变为慢性疼痛的myo1a以及myo1a用于治疗疼痛的用途 |
-
2023
- 2023-05-24 AR ARP230101325A patent/AR129441A1/es unknown
- 2023-05-25 US US18/868,199 patent/US20250213654A1/en active Pending
- 2023-05-25 KR KR1020247041847A patent/KR20250017221A/ko active Pending
- 2023-05-25 IL IL317048A patent/IL317048A/en unknown
- 2023-05-25 AU AU2023275937A patent/AU2023275937A1/en active Pending
- 2023-05-25 CN CN202380053577.6A patent/CN119730868A/zh active Pending
- 2023-05-25 CA CA3253053A patent/CA3253053A1/en active Pending
- 2023-05-25 JP JP2024569387A patent/JP2025519127A/ja active Pending
- 2023-05-25 EP EP23728752.9A patent/EP4531886A1/en active Pending
- 2023-05-25 WO PCT/EP2023/064091 patent/WO2023227731A1/en not_active Ceased
- 2023-05-25 TW TW112119546A patent/TW202409064A/zh unknown
-
2024
- 2024-11-21 MX MX2024014419A patent/MX2024014419A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220280593A1 (en) | Methods for performing a coronary artery bypass graft procedure | |
| JP2019089773A (ja) | ミトコンドリア透過性転移の阻止方法 | |
| JP6518197B2 (ja) | バース症候群の予防または治療のための方法及び組成物 | |
| CN106620645A (zh) | 预防或治疗缺血/再灌注损伤之后无复流的方法 | |
| US20260008810A1 (en) | Analogs that target mitochondrial diseases | |
| AU781678C (en) | Compositions and methods for counteracting effects of reactive oxygen species and free radicals | |
| FI3746467T3 (fi) | Muutetut lipidoidut relaksiinin b-ketjun peptidit ja niiden terapeuttinen käyttö | |
| JP6529606B2 (ja) | 自己免疫障害及び炎症障害を治療及び/又は予防するための短い合成ペプチド | |
| KR20160009008A (ko) | 심부전과 관련된 위험 및 이와 관련된 인자를 감소시키는 방법 | |
| WO2021040526A1 (en) | Q-er peptide | |
| JP2022506716A5 (cg-RX-API-DMAC7.html) | ||
| JP2025121987A (ja) | Glp-1/glp-2デュアルアゴニストの医薬組成物 | |
| JP7809117B2 (ja) | Glp-1/glp-2デュアルアゴニストの医薬組成物 | |
| JP2024547029A5 (cg-RX-API-DMAC7.html) | ||
| US20080306075A1 (en) | Pharmaceutical Compositions For Transdermal Delivery | |
| US5840697A (en) | Peptide inhibitors of calmodulin | |
| WO2011053191A1 (ru) | Средство для лечения связанных со стрессовыми условиями заболеваний и расстройств у человека и животных, а также способ лечения и/или профилактики с использованием этого средства | |
| JP2023544910A (ja) | コロナウイルス治療法 | |
| Kutina et al. | Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats | |
| US10391154B2 (en) | Compositions and methods for treating or ameliorating fibrosis, systemic sclerosis and scleroderma | |
| WO2006101909A2 (en) | Combination therapy for treating or preventing diseases | |
| KR102689456B1 (ko) | 알파-1 안티트립신을 포함하는 면역억제제에 의한 신장손상 예방 또는 치료용 조성물 | |
| CN119708140A (zh) | 肽化合物及其治疗疾病的方法 | |
| WO2003020301A1 (en) | Chromogranin a and fragments thereof for the treatment of diseases involving increased vascular permeability | |
| WO2025123051A1 (en) | Non-naturally occurring melanocortin analogs and uses thereof for modulating weight gain |